NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.050
-0.050 (-4.55%)
Jun 11, 2026, 5:29 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 116.96 million as of June 11, 2026. Its market cap has increased by 53.87% in one year.
Market Cap
116.96M
Enterprise Value
84.63M
Revenue
9.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.05
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 116.96M, an increase of 254.15%. That is a compound annual growth rate of 15.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 122.53M | 50.48% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diamyd Medical AB | 167.69M |
| Nanologica AB | 167.02M |
| AlzeCure Pharma AB | 159.16M |
| Alligator Bioscience AB | 123.86M |
| Simris Group AB (PUBL) | 119.32M |
| Biovica International AB | 105.38M |
| IRLAB Therapeutics AB | 105.32M |
| OncoZenge AB | 96.65M |